Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
Real-time Quote. Real-time Euronext Paris - 01/26 11:38:02 am
91.94 EUR   +1.87%
02:22aSANOFI : JP Morgan reiterates its Buy rating
MD
01:46aBusiness investment into Singapore dropped 31% in 2021
RE
01:43aBusiness investment into Singapore dropped 31% in 2021
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SANOFI : Gets a Buy rating from Goldman Sachs

11/11/2021 | 04:57am EST

In a research note, Goldman Sachs analyst Keyur Parekh has maintained his recommendation on the stock with a Buy rating. The target price is being increased from EUR 113 to EUR 124.


© MarketScreener with dpa-AFX Analyser 2021
All news about SANOFI
02:22aSANOFI : JP Morgan reiterates its Buy rating
MD
01:46aBusiness investment into Singapore dropped 31% in 2021
RE
01:43aBusiness investment into Singapore dropped 31% in 2021
RE
01/25SANOFI : Disclosure of trading in own shares
PU
01/25Liberum Reinstates Sanofi With Buy Rating
MT
01/24SANOFI : Second positive Phase 3 Dupixent® (dupilumab) trial confirms significant improvem..
PU
01/21SANOFI : Early redemption / Cancellation / Delisting
PU
01/20Exclusive-Polish drug maker Polpharma working on bid for Advent's Zentiva - sources
RE
01/19Regeneron Says FDA to Review Libtayo/Chemotherapy Combo in First-Line NSCLC Treatment
DJ
01/19Sanofi, Regeneron Say Dupixent Significantly Reduces Itching in Prurigo Nodularis Patie..
MT
More news
Analyst Recommendations on SANOFI
More recommendations
Financials
Sales 2021 37 786 M 42 404 M 42 404 M
Net income 2021 6 139 M 6 890 M 6 890 M
Net Debt 2021 9 925 M 11 138 M 11 138 M
P/E ratio 2021 18,9x
Yield 2021 3,59%
Capitalization 115 B 130 B 130 B
EV / Sales 2021 3,32x
EV / Sales 2022 3,04x
Nbr of Employees 99 412
Free-Float -
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 91,94 €
Average target price 107,27 €
Spread / Average Target 16,7%
EPS Revisions
Managers and Directors
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Director
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capi. (M$)
SANOFI3.79%127 797
JOHNSON & JOHNSON-2.01%441 302
ROCHE HOLDING AG-8.68%304 745
PFIZER, INC.-11.02%294 900
ABBVIE INC.-1.71%235 287
ELI LILLY AND COMPANY-13.31%217 093